Table 3 Number of subjects in the intervention group displaying serum ALT above reference levels during the study and at follow-up
ALT reference levelsBaseline (men n = 12, women n = 6)Week 1 (men n = 12, women n = 6)Week 2 (men n = 12, women n = 6)Week 3 (men n = 11, women n = 6)Week 4 (men n = 11*, women n = 6)Persistent elevation from week 1 to study endFollow-up after 6 months (n = 17**)
Men >40 U/l†1756851
Men >30 U/l††2911101083
Women >31 U/l†0233210
Women >19 U/l††1543432
  • *One subject that had returned to regular eating habits during the fourth week is included.

  • **One subject lost to follow-up due to studies abroad.

  • †Upper reference limits for ALT used in NHANES III.1

  • ††Updated upper reference limits for ALT.22